Adicet Bio (NASDAQ:ACET – Get Free Report) is scheduled to announce its earnings results on Tuesday, August 8th. Adicet Bio (NASDAQ:ACET – Get Free Report) last announced its quarterly earnings data on Tuesday, May 9th. The company reported ($0.72) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.74) by $0.02. On […]
Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) was the recipient of a significant decrease in short interest during the month of July. As of July 15th, there was short interest totalling 2,960,000 shares, a decrease of 5.7% from the June 30th total of 3,140,000 shares. Based on an average trading volume of 835,400 shares, […]
Carlyle Group Inc. acquired a new position in shares of Adicet Bio, Inc. (NASDAQ:ACET – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,115,385 shares of the company’s stock, valued at approximately $12,163,000. Adicet Bio comprises […]
Adicet Bio, Inc. (NASDAQ:ACET – Free Report) Director Steve Dubin bought 5,000 shares of Adicet Bio stock in a transaction on Friday, June 30th. The stock was purchased at an average price of $2.40 per share, with a total value of $12,000.00. Following the completion of the acquisition, the director now directly owns 10,900 shares […]
Adicet Bio (NASDAQ:ACET – Free Report) had its target price cut by BTIG Research from $34.00 to $20.00 in a research note released on Tuesday morning, The Fly reports. A number of other equities analysts also recently weighed in on the stock. JPMorgan Chase & Co. downgraded shares of Adicet Bio from an overweight rating […]